期刊文献+

早期黏膜下浸润与非黏膜下浸润结直肠癌的差异蛋白鉴定

Identification of differential proteins between early submucosal invasive and non-invasive colorectal cancer
原文传递
导出
摘要 目的构建大鼠早期黏膜下浸润结直肠癌(SICRC)与非黏膜下浸润结直肠癌(SNICRC)模型并鉴定两者的差异蛋白,以筛选早期SICRC的生物学标记。方法应用N一甲基一N一亚硝基脲(MNU)诱导建立大鼠SICRC与SNICRC模型。二维荧光差异定量双向电泳技术(2D-DIGE)和基质辅助激光解吸/电离.飞行时间质谱鉴定出SICRC与SNICRC的差异蛋白。荧光定量Real.timePCR和Westernblot实验验证所选蛋白的鉴定结果。结果成功建立大鼠SICRC与SNICRC模型。2D-DIGE发现SICRC和SNICRC之间有5个差异表达蛋白(P值均〈0.01)。质谱分析鉴定这5个蛋白发现,与SNICRC和正常对照(NC)比较,转凝蛋白(Transgelin)、肽基脯氨酰异构酶A和原肌球蛋白1在SICRC表达上调,而碳酸酐酶lI(CAII)与一种未命名蛋白表达下凋。Real-timePCR和Westernblot验证结果显示,TransgelinmRNA和蛋白水平在SICRC组(33.05±0.75、86.63±1.83)高于SNICRC(22.68-4-0.89、67.93±2.39)和NC组(18.07±0.55、44.25±1.55)(P值均〈0.05),而CAlImRNA和蛋白水平在SICRC组(18.014-0.53、41.55±1.89)低于SNICRC组(26.284-1.08、61.114-1.57)和NC组(33.08±0.76、83.434-1.61)(P值均〈0.05),变化趋势与蛋白质组学一致。 Objective To construct tumor models of early submucosal invasive colorectal cancer (SICRC) and submucosal non-invasive colorectal cancer (SNICRC) in rats, identify the differential proteins between SICRC, SNICRC and normal control (NC) and screen the biomarkers for early detection and diagnosis of SICRC. Methods N-methyl-N-nitrosourea (MNU) was used to induce tumor models of SICRC and SNICRC in rats. 2D-DIGE and MOLDI-TOF-MS/MS were applied to identify the differential pro- teins between SICRC, SNICRC and NC. Quantitative real-time polymerase chain reaction (PCR) and Western blotting assays confirmed the validation of 2D-DIGE analysis. Results MNU-induced tumor mod- els of SICRC and SNICRC in rats were successfully constructed and five differential proteins were found be- tween SICRC, SNICRC and NC by 2D-DIGE ( each P 〈 0. 01 ). The identified results using mass spec- trometry showed that Transgelin, Peptidylprolyl isomerase A and Tropomyosin 1 were up-regulated, while carbonic anhydrase 2 ( CA I1 ) and an unnamed protein were down-regulated in SICRC compared with SNI- CRC and NC. Furthermore, consistent with the proteomics, real-time PCR and Western blottoing assays demonstrated that the relative mRNA and protein levels of Transgelin were highly expressed in SICRC (33.05 ± O. 75, 86. 63 ± 1.83 ) as compared with SNICRC ( 22. 68 ±O. 89, 67. 93 ±2. 39 ) and NC ( 18. 07± O. 55, 44. 25 ± 1.55 ) ( each P 〈 0. 05 ), while those of CA II were weakly expressed in SICRC (18.01±0.53, 41.55 ±1.89) as compared with SNICRC (26.28±1.08, 61.11±1.57) and NC (33. 08 ± O. 76, 83.43 ±1.61 ) ( each P 〈 0.05). Conclusion 2D-DIGE technique is an effective way to screen the differential proteins between early SICRC and SNICRC and identified proteins such as Transgelin and CA II may be the potential biomarkers for early detection and diagnosis of SICRC.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第2期187-190,共4页 Chinese Journal of Experimental Surgery
基金 上海市科委资助项目(10140902500)
关键词 结直肠癌 蛋白质组学 质谱法 转凝蛋白 碳酸酐酶Ⅱ Colorectal cancer Proteomics Mass spectrometry Transgelin Carbonic an-hydrase 2
  • 相关文献

参考文献11

  • 1Zell JA. Clinical trials update:Tertiary prevention of colorectal canc- er. J Carcinog,2011,10:8.
  • 2柏斗胜,樊嘉,代智,周俭,刘银坤.肝癌肝移植术后复发转移相关分子的定量蛋白质组学研究[J].中华实验外科杂志,2007,24(12):1517-1519. 被引量:10
  • 3Friedman DB, Hill S, Keller JW, et al. Proteome analysis of human co- lon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics ,2004,4 : 793-811.
  • 4Schlemper R J, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut,2000,47 : 251-255.
  • 5张剑锋,高春芳,郑国宝,王秀丽,李冬晖,陈建平.结直肠癌Dukes B、C、D期患者血清比较蛋白质组学研究[J].中华实验外科杂志,2006,23(11):1348-1350. 被引量:11
  • 6Shields JM, Rogers-Graham K, Der CJ. Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expres- sion through Raf-independent pathways. J Biol Chem, 2002, 277: 9790-9799.
  • 7Yeo M, Kim DK, Park H J, et al. Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis. Proteomics, 2006,6 : 1158-1165.
  • 8Lee EK, Hart GY, Park HW, et al. Transgelin promotes migration and invasion of cancer stem cells. J Proteome Res,2010,9:5108-5117.
  • 9Bekku S, Mochizuki H, Yamamoto T,et al. Expression of carbonic an- hydrase I or II and correlation to clinical aspects of colorectal cancer. Hepatogastroenterology, 2000,47 : 998 - 1001.
  • 10Yokoyama S, Shatney CH, Mochizuki H, et al. The potential role of fe- cal carbonic anhydrase II in screening for colorectal cancer. Am Surg, 1997,63:243-247.

二级参考文献7

  • 1高春芳,赵光,郑国宝,李冬晖,王秀丽.利用血清中蛋白质组构型鉴定Dukes A期结直肠癌[J].解放军医学杂志,2005,30(6):460-462. 被引量:11
  • 2贺轶锋,樊嘉,周俭,吴志全,邱双健,黄晓武,余耀,孙健,肖永胜,杨国欢,宋康,王征,汤钊猷,王玉琦.影响肝癌肝移植预后的高危因素分析及诊治经验[J].中华医学杂志,2006,86(18):1232-1235. 被引量:27
  • 3Wong LL. Current status of liver transplantation for hepatocellular cancer. Am J Surg,2002,183:309-316.
  • 4Ye QH, Qin LX, Forgues M, et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med,2003,9:416-423.
  • 5Fields S. Proteomics in genome land. Science ,2001,291:1221-1224.
  • 6Steven PG, Beate R, Scott AG, et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotechnology, 1999,17:994-1000.
  • 7Perrin BJ, Huttenlocher A. Molecules in focus Calpain. Inter J Biochem Cell Bio,2002,34:722-725.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部